10x Genomics (TXG) Deferred Taxes (2018 - 2019)

10x Genomics (TXG) posted Deferred Taxes of -$111000.0 for Q4 2019, down 109.64% sequentially from $1.2 million in Q3 2019, and down 103.88% YoY from $2.9 million in Q4 2018.

10x Genomics (TXG) Deferred Taxes (2018 - 2019) Analysis & Trends

10x Genomics has reported Deferred Taxes for 2 years, with the latest figure at -$111000.0 in Q4 2019.

  • Quarterly Deferred Taxes fell 103.88% year-over-year to -$111000.0 in Q4 2019, while the trailing twelve-month figure through Dec 2020 was $1.0 million (down 91.83% YoY) and the FY2019 annual result came in at $12.7 million, up 282.51% from the prior year.
  • Deferred Taxes retreated to -$111000.0 in Q4 2019 per TXG's latest filing, from $1.2 million in the prior quarter.
  • Over five years, Deferred Taxes peaked at $7.3 million in Q1 2019 and troughed at -$111000.0 in Q4 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Veeva Systems 39.72 Bn 32.40 Bn 662.02 Mn 14.34 Mn
2 BrightSpring Health Services 12.19 Bn 11.64 Bn 492.75 Mn -2.34 Mn
3 Healthequity 8.79 Bn 8.52 Bn 256.31 Mn 10.11 Mn
4 10x Genomics 7.31 Bn 6.76 Bn 112.50 Mn -
5 Hinge Health 7.10 Bn 6.71 Bn 183.95 Mn 13,000.00
6 MiniMed 5.66 Bn 5.36 Bn 480.00 Mn -55.00 Mn
7 Waystar Holding 4.76 Bn 4.56 Bn 221.99 Mn -34.58 Mn
8 Doximity 4.46 Bn 3.77 Bn 132.93 Mn -
9 Heartflow 3.66 Bn 3.28 Bn 53.19 Mn -
10 Privia Health 2.78 Bn 2.42 Bn - 1.16 Mn

Historic Data

Download Data
DateValue
Dec 31, 2019 -111,000.00
Sep 30, 2019 1.15 Mn
Jun 30, 2019 4.41 Mn
Mar 31, 2019 7.28 Mn
Dec 31, 2018 2.86 Mn